11 / 17
Page 101
May 24-25, 2018
London, UK
Vascular Surgery 2018
3
rd
Edition of World Congress & Exhibition on
Vascular Surgery
Journal of Vascular and Endovascular Therapy
ISSN: 2573-4482
Objective:
to evaluate the efficiency of the hemodialysis catheter
in the femoral tunnel as durable access for patients with
hemodialysis.
Introduction:
Vascular access (VA) continues to be the keystone
in cases requiring hemodialysis (HD). When the choices of arterial
venous fistula, grafts, and thoracic central catheters are depleted,
the case’s life becomes at risk. The extra options are limited to
transplantation, peritoneal dialysis, insertion of the trans lumbar
and femoral catheter. The Last may, in lots of cases, be the best
choice. We present our experience at the Matarya Teaching
Hospital with 17 cases where all vascular accesses was depleted
and no transplant or peritoneal dialysis could be performed.
Therefore, we chose the femoral tunnel catheter (FTC) as VA
durable and unique. The median follow-up period was 10 months
(2-14 months). The median age of cases was 55 (40-70) years.
In ten cases, a Permcath (Hickman access system, BARD) and
the other seven are inserted (DURAFLOW, from AngioDynamics).
All cases received warfarin after passing LMWH to prevent
thrombosis of the catheter. All catheters were functional for
2 months. The mean blood flow was 230 ml / min (200-260 ml
/ min). Two cases died at 5 and 12 months respectively with a
functional catheter due to causes not directly related to the FTC.
In a patient, the site of the catheter was changed to 5 months due
to an accidental catheter slipping. A catheter has been changed
because the flow has become inadequate after 8 months. No
patient had deep vein thrombosis. In one patient, the catheter
was operated for 14 months after insertion. We conclude that
the femoral catheter in the tunnel is a stable option in cases with
depleted VA.
Recent Publications
1. PervezA,ZamanF,AslamA,etal.Portcatheterplacement
by nephrologists in an interventional nephrology training
program. Semin Dial 2004; 71:61-4.
2. Mermel LA. Prevention of intravascular catheter-
related infection. Ann Intern Med 2000; 132:391-402.
[PUBMED] [FULLTEXT]
3. Daniel T, Murai MD. Are femoral broviac catheters
effective and safe? A prospective comparison of femoral
and jugular boviac catheters in newborn infants. Chest
2002; 121:1527-30.
4. Pierco CM, Wade A, Moke Q, et al. Heparin-bonded
central venous lines reduce thrombotic and infective
complications in critically ill children. Intensive CareMed
2000; 26:967-72.
5. Joynt GM, Kew J, Gomersall CD, et al. Deep venous
thrombosis caused by femoral venous catheters in
critically ill adult patients. Chest 2000; 117:178-83.
[PUBMED] [FULLTEXT].
Biography
Assem is a junior cosultant vascular surgeon in Matarya Teaching Hospital;
Cairo; Egypt.one of the big vascular centres in Egypt. He has a fair experi-
ence in both open and endovascular procedures.MSC.MRCS. & M.D.
assemherz010@hotmail.comFemoral Tunneled Hemodialysis Catheter as a permanent
access for hemodialysis patients
Herzallah AM
Matarya Teaching Hospital, Egypt.
Herzallah AM, J Vasc Endovasc Therapy 2018, Volume 3
DOI: 10.21767/2573-4482-C1-003